P

Inventor

HOPKINS BRIAN T

US34 patents
⚠️ This page may combine multiple inventors who share the name “HOPKINS BRIAN T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BIOGEN MA INC

18 patents
US9809577B2Nov 7, 2017

Biaryl inhibitors of Bruton's tyrosine kinase

BIOGEN MA INC12 citations92
US10227341B2Mar 12, 2019

Inhibiting agents for bruton's tyrosine kinase

BIOGEN MA INC8 citations83
US10081619B2Sep 25, 2018

Biaryl inhibitors of bruton's tyrosine kinase

BIOGEN MA INC7 citations83
US9790229B2Oct 17, 2017

Bruton's tyrosine kinase inhibitors

BIOGEN MA INC11 citations83
US10961237B2Mar 30, 2021

Inhibiting agents for Bruton's tyrosine kinase

BIOGEN MA INC4 citations82
US10189829B2Jan 29, 2019

Inhibiting agents for Bruton's tyrosine kinase

BIOGEN MA INC6 citations82
US9944622B2Apr 17, 2018

Pyrimidinyl tyrosine kinase inhibitors

BIOGEN MA INC8 citations82
US10759783B2Sep 1, 2020

Biaryl inhibitors of Bruton'S tyrosine kinase

BIOGEN MA INC3 citations72
US11427577B2Aug 30, 2022

Inhibiting agents for Bruton's tyrosine kinase

BIOGEN MA INC2 citations71
US12391697B2Aug 19, 2025

Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase

BIOGEN MA INC1 citations63
US11572356B2Feb 7, 2023

Biaryl inhibitors of Bruton's tyrosine kinase

BIOGEN MA INC0 citations62
US11858926B2Jan 2, 2024

Inhibiting agents for bruton's tyrosine kinase

BIOGEN MA INC0 citations61
US10899753B2Jan 26, 2021

Inhibiting agents for Bruton's tyrosine kinase

BIOGEN MA INC1 citations61
US10280169B2May 7, 2019

Biaryl bruton's tyrosine kinase inhibitors

BIOGEN MA INC1 citations56
US12565500B2Mar 3, 2026

Substituted pyrrolo[1,2-b]pyridazines and pyrrolo[2,1-f][1,2,4]triazines as Btk inhibitors

BIOGEN MA INC0 citations51
US12240838B2Mar 4, 2025

Inhibiting agents for Bruton's tyrosine kinase

BIOGEN MA INC0 citations51
US10189817B2Jan 29, 2019

Inhibitors of Bruton's tyrosine kinase

BIOGEN MA INC0 citations49
US12570631B2Mar 10, 2026

Substituted N-(4-(pyrimidin and pyridin-4-yl)benzylcarboxamides and its use for treating disorders responsive to inhibition of Btk

BIOGEN MA INC0 citations45

CASTRO ALFREDO C

5 patents

BIOGEN IDEC INC

3 patents

BUI MINNA

2 patents

INFINITY PHARMACEUTICALS INC

2 patents

SUNESIS PHARMACEUTICALS INC

2 patents

HOPKINS BRIAN T

1 patent

INFINITY DISCOVERY INC

1 patent